24 Roy Street, #437
Seattle, WA 98109
Complete this contact form for media, investor relations and partnership/business development inquiries
Please leave this field empty.
* required fields
A Feasibility Study of the Nativis Voyager System in Patients with Recurrent Glioblastoma Multiforme (rGBM). This study is currently recruiting qualified patients.
Abstract presented by Xavier Figueroa, PhD, at Society for Neuro-Oncology 2016 Annual Conference, Scottsdale, AZ on November 19, 2016.
The latest information on publications highlighting Nativis research and advancements.
October 17, 2017
Nativis Research Partner to Present at COGNO Conference in Australia
October 3, 2017
Nativis Announces Engagement of Strategic Financial Advisory Firm Outcome Capital, LLC
September 20, 2017
Nativis to Present at the Ladenburg Thalmann 2017 Healthcare Conference
Nativis Voyager® ulRFE™ System for rGBM is an investigational medical device. Limited by Federal (or United States) law to investigational use only.
© Nativis 2015 - 2017